Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample

Brain, Behavior, and Immunity

Volumn 41, Issue 1, 2014, Pages 55-58

  Kern, Silke ^a   Skoog, Ingmar ^a   Börjesson Hanson, Anne ^a   Blennow, Kaj ^a   Zetterberg, Henrik ^a,b   Östling, Svante ^a   Kern, Jürgen ^a   Gudmundsson, Pia ^a   Marlow, Thomas ^a   Rosengren, Lars ^a   Waern, Margda ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CSF; Depression; Interleukin 6; Interleukin 8; Older women; Population based; Prospective

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

AGED; ARTICLE; CEREBROSPINAL FLUID; COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE; DEPRESSION; DISEASE ASSOCIATION; DSM-IV; FEMALE; FOLLOW UP; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MENTAL DISEASE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; AGING; DEPRESSIVE DISORDER; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SWEDEN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; INTERVIEW, PSYCHOLOGICAL; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWEDEN;

EID: 84924024740     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.05.006     Document Type: Article

References (24)

1. Baune B.T., Smith E., Reppermund S., Air T., Samaras K., et al. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 2012, 37:1521-1530.
2. Beumer W., Gibney S.M., Drexhage R.C., Pont-Lezica L., Doorduin J., et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 2012.
3. Brambilla F., Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr. Scand. 1998, 97:309-313.
4. Buchhave P., Minthon L., Zetterberg H., Wallin A.K., Blennow K., Hansson O. Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10years before the onset of alzheimer dementia. Arch. Gen. Psychiatry 2012, 69:98-106.
5. Carpenter L.L., Heninger G.R., Malison R.T., Tyrka A.R., Price L.H. Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. J. Affect. Disord. 2004, 79:285-289.
6. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
7. Gudmundsson P., Skoog I., Waern M., Blennow K., Palsson S., et al. The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am. J. Geriatr. Psychiatry 2007, 15:832-838.
8. Hiles S.A., Baker A.L., de Malmanche T., Attia J. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav. Immun. 2012, 26:1180-1188.
9. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
10. Isung J., Aeinehband S., Mobarrez F., Martensson B., Nordstrom P., et al. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl. Psychiatry 2012, 2:e196.
11. Kern S., Skoog I., Borjesson-Hanson A., Blennow K., Zetterberg H., et al. Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years. Brain Behav. Immun. 2013, 32:153-158.
12. Levine J., Barak Y., Chengappa K.N., Rapoport A., Rebey M., Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999, 40:171-176.
13. Lindqvist D., Janelidze S., Hagell P., Erhardt S., Samuelsson M., et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry 2009, 66:287-292.
14. Lu Y., Feng L., Feng L., Nyunt M.S., Yap K.B., Ng T.P. Systemic inflammation, depression and obstructive pulmonary function: a population-based study. Respir. Res. 2013, 14:53.
15. Martinez J.M., Garakani A., Yehuda R., Gorman J.M. Proinflammatory and "resiliency" proteins in the CSF of patients with major depression. Depress. Anxiety 2011.
16. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
17. Norden D.M., Godbout J.P. Microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol. Appl. Neurobiol. 2012.
18. O'Connor M.F., Bower J.E., Cho H.J., Creswell J.D., Dimitrov S., et al. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 2009, 23:887-897.
19. Reyes-Gibby C.C., Wang J., Spitz M., Wu X., Yennurajalingam S., Shete S. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J. Pain Symptom Manage. 2013, 46:161-172.
20. Sasayama D., Hattori K., Wakabayashi C., Teraishi T., Hori H., et al. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J. Psychiatr. Res. 2013, 47:401-406.
21. Skoog I., Nilsson L., Palmertz B., Andreasson L.A., Svanborg A. A population-based study of dementia in 85-year-olds. N. Engl. J. Med. 1993, 328:153-158.
22. Stewart J.C., Rand K.L., Muldoon M.F., Kamarck T.W. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav. Immun. 2009, 23:936-944.
23. Stubner S., Schon T., Padberg F., Teipel S.J., Schwarz M.J., et al. Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130. Neurosci. Lett. 1999, 259:145-148.
24. Vogelzangs N., Duivis H.E., Beekman A.T., Kluft C., Neuteboom J., et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl. Psychiatry 2012, 2:e79.